TRVI · Categories · Form 4
TRVI - SEC Form 4 insider transactions
Trevi Therapeutics Inc. (TRVI) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for TRVI
- SEC Form 4 filed by Director Mathers Edward T4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Director Colangelo Dominick4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Director Vanlent Anne4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Director Heffernan Michael Thomas4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Director Meeker David P4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Chief Development Officer Cassella James V4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Officer Galletta Christopher4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Sciascia Thomas4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by President & CEO Good Jennifer L4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Simon Farrell4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Hastings David C4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- Officer Galletta Christopher exercised 4,225 shares at a strike of $0.51, increasing direct ownership by 19% to 26,095 units (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Director Mathers Edward T4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Director Meeker David P4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Director Heffernan Michael Thomas4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Director Vanlent Anne4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Director Colangelo Dominick4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Sciascia Thomas4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Simon Farrell4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Officer Galletta Christopher4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Delfini Lisa4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by President & CEO Good Jennifer L4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- Chief Scientific Officer Sciascia Thomas exercised 2,631 shares at a strike of $1.43 and sold $17,365 worth of shares (2,631 units at $6.60) (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- President & CEO Good Jennifer L exercised 5,263 shares at a strike of $1.43 and sold $34,625 worth of shares (5,263 units at $6.58) (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Sciascia Thomas4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Delfini Lisa4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by President & CEO Good Jennifer L4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- Chief Commercial Officer Simon Farrell exercised 112,563 shares at a strike of $2.86 and sold $548,878 worth of shares (81,313 units at $6.75), increasing direct ownership by 68% to 76,900 units (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Officer Galletta Christopher4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Sciascia Thomas4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Chief Development Officer Cassella James V4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Simon Farrell4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Delfini Lisa4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Officer Galletta Christopher4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by President & CEO Good Jennifer L4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- Chief Financial Officer Delfini Lisa exercised 6,000 shares at a strike of $0.51, increasing direct ownership by 10% to 64,660 units (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- Officer Galletta Christopher exercised 15,000 shares at a strike of $0.51, increasing direct ownership by 304% to 19,935 units (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Chief Development Officer Cassella James V4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- President & CEO Good Jennifer L exercised 6,059 shares at a strike of $1.43 and sold $18,371 worth of shares (6,059 units at $3.03) (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- President & CEO Good Jennifer L exercised 55,121 shares at a strike of $1.43 and sold $170,193 worth of shares (55,121 units at $3.09) (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- Director Meeker David P exercised 4,555 shares at a strike of $1.43 and sold $13,353 worth of shares (4,555 units at $2.93) (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- Chief Scientific Officer Sciascia Thomas exercised 16,496 shares at a strike of $1.43 and sold $48,883 worth of shares (16,496 units at $2.96) (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- Chief Scientific Officer Sciascia Thomas exercised 31,505 shares at a strike of $1.43 and sold $87,228 worth of shares (31,505 units at $2.77) (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Director Mathers Edward T4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Director Cassella James V4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Director Vanlent Anne4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Director Heffernan Michael Thomas4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Director Colangelo Dominick4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Director Meeker David P4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- Sciascia Thomas exercised 59,354 shares at a strike of $2.19 and sold $136,110 worth of shares (53,368 units at $2.55), increasing direct ownership by 3% to 214,433 units (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- Delfini Lisa exercised 16,043 shares at a strike of $0.51 and sold $11,485 worth of shares (4,350 units at $2.64), increasing direct ownership by 28% to 53,279 units (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- Good Jennifer L exercised 25,037 shares at a strike of $2.19 and sold $71,576 worth of shares (25,037 units at $2.86) (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- Good Jennifer L exercised 4,578 shares at a strike of $2.19 and sold $13,276 worth of shares (4,578 units at $2.90) (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Galletta Christopher4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Simon Farrell4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Clark David J4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Good Jennifer L4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Sciascia Thomas4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- SEC Form 4 filed by Delfini Lisa4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)
- Delfini Lisa exercised 2,292 shares at a strike of $0.51 and sold $1,586 worth of shares (785 units at $2.02), increasing direct ownership by 4% to 35,901 units (SEC Form 4)4 - Trevi Therapeutics, Inc. (0001563880) (Issuer)